Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: Insights from a Pilot Implementation Program
Canadian journal of diabetes, 2026
Tirzepatide Regulates Pacemaker Function by Modulating cAMP and Calcium Dynamics in Human Sinoatrial Node Cells
Circulation, 2026;153(25):2110-2113
Clinical Impact of Semaglutide in Patients with Heart Failure and Preserved Ejection Fraction
Journal of clinical medicine, 2026;15(12)
Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review
International journal of molecular sciences, 2026;27(12)
Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids-Application to recent real-world cases
Drug metabolism and disposition: the biological fate of chemicals, 2026;54(8):100346
Dysregulation of circulating damage-associated molecular patterns in diabetic foot syndrome
Frontiers in immunology, 2026;17:1849387
Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence
Cureus, 2026;18(6):e111322
Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024
Acta psychiatrica Scandinavica, 2026
Short- and Long-term Effects of Semaglutide 2.4 mg on Energy Intake, Appetite, and Food Reward: A 60-week, Double-Blind Randomized Controlled Trial
The American journal of clinical nutrition, 2026;:101403
Long-term effects of weight-reducing drugs in people with hypertension
The Cochrane database of systematic reviews, 2026;6:CD007654
Pulmonary adverse events associated with GLP-1 receptor agonists: a systematic review of respiratory safety signals
Cardiovascular diabetology. Endocrinology reports, 2026;12(1)
Effect of GLP-1 receptor agonists at doses for obesity management on muscle health: systematic review and meta-analysis of randomized controlled trials (RCTs)
International journal of obesity (2005), 2026
Efficacy of Initiation of Semaglutide versus SGLT2 inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Multicenter Propensity-Matched Real-World Study
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026
Anterior Cutaneous Nerve Entrapment Syndrome From Glucagon-Like Peptide-1 Receptor Agonist Injection
ACG case reports journal, 2026;13(6):e02168
Glucagon-like Peptide-1 Receptor Agonists and Alcohol Use Outcomes: A Systematic Review of Clinical Evidence
Journal of clinical medicine, 2026;15(12)
Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials
EClinicalMedicine, 2026;97:104026
Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial
Contemporary clinical trials communications, 2026;52:101660
Case Report: Dramatic metabolic improvement with tirzepatide in a patient with acquired partial lipodystrophy following hematopoietic stem cell transplantation
Frontiers in endocrinology, 2026;17:1868458
Functional segregation of body-brain signals in the area postrema
bioRxiv : the preprint server for biology, 2026
A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
JAMA, 2026